BLUEBIRD STRATEGIES

Lobbying for MYOTONIC · Patient advocacy organization.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · posted Jul 6, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program.

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.